Are these measures, that information, required in the contract by those--that each individual provider has to be able to...
It is probably much better than a nail salon.
Then the next question, because I think you touched on it a little bit, but how is it that we are able to reach out to o...
If PBMs were doing such a good job on my behalf negotiating for Part D, for example, why am I paying so much more than t...
The time I believe to act is now.
I feel that on this subcommittee where we have a very broad jurisdiction, we have been able to pass some important bills...
The legislation has a two-fold purpose. First, it will provide the Federal Trade Commission with authority to take actio...
My bill will allow for greater transparency in drug pricing.
It is clear from the testimony that we have heard today that Congress has an opportunity to act to combat the gaming tac...
But competition is actually most central to innovation--and the opposite of what Big Pharma wants.
So we owe it to the American people, and I will be doing everything I can in my power to do so.
Instead of truly innovating, drug manufacturers are taking advantage of the anticompetitive environment we have created.
drug manufacturers are gaming the system to make more money at consumers' expense, and that has to stop.
Product hopping or evergreening is the reformulation of a drug by a brand-name manufacturer to delay competition and pro...
Competition is crucial to lowering prescription drug prices and improving America's access to lifesaving medication.
We can't leave any stone unturned in examining ways to address this issue.
I am proud to preside over this hearing in the Consumer Protection Subcommittee because Congress must take direct action...
competition is actually more central to innovation, and the opposite of what Big Pharma wants.
